We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
+12.24%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$94.5M
AUM Growth
+$10.7M
Cap. Flow
+$890K
Cap. Flow %
0.94%
Top 10 Hldgs %
98.17%
Holding
26
New
6
Increased
10
Reduced
2
Closed
7
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDGL icon
1
Madrigal Pharmaceuticals
MDGL
$12.8B
$82.6M 87.47%
1,058,891
+87
+0% +$7.3K
CPXX
2
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
$5.03M 5.33%
2,246,469
GDX icon
3
VanEck Gold Miners ETF
GDX
$21.8B
$1.3M 1.38%
+73,274
New +$1.42M
ACAS
4
DELISTED
American Capital Ltd
ACAS
$1.04M 1.1%
76,434
+11,379
+17% +$165K
ESL
5
DELISTED
Esterline Technologies
ESL
$628K 0.66%
6,590
-517
-7% -$55.3K
ST icon
6
Sensata Technologies
ST
$6.55B
$572K 0.61%
10,853
+219
+2% +$12.3K
IVTY
7
DELISTED
Invuity, Inc
IVTY
$479K 0.51%
+33,905
New +$493K
PHD
8
DELISTED
Pioneer Floating Rate Fund
PHD
$417K 0.44%
36,637
+3,763
+11% +$43.7K
MDLY
9
DELISTED
Medley Management Inc
MDLY
$333K 0.35%
2,817
+41
+1% +$4.74K
EVF
10
Eaton Vance Senior Income Trust
EVF
$90.1M
$307K 0.32%
49,460
+3,801
+8% +$24.6K
PFX icon
11
PhenixFIN
PFX
$88.7M
$286K 0.3%
1,603
+5
+0.3% +$919
FSAM
12
DELISTED
Fifth Street Asset Management Inc. Class A
FSAM
$273K 0.29%
+26,562
New +$279K
OXSQ icon
13
Oxford Square Capital
OXSQ
$153M
$209K 0.22%
31,142
+7,400
+31% +$51K
BRK.B icon
14
Berkshire Hathaway Class B
BRK.B
$1.06T
$206K 0.22%
+1,511
New +$216K
NSL
15
DELISTED
NUVEEN SENIOR INCM FD
NSL
$199K 0.21%
31,142
+1,365
+5% +$9.1K
AGRX
16
DELISTED
Agile Therapeutics
AGRX
$151K 0.16%
9
-4
-31% -$85.4K
FRA icon
17
BlackRock Floating Rate Income Strategies Fund
FRA
$380M
$149K 0.16%
10,991
+33
+0.3% +$457
VIRX
18
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$144K 0.15%
+228
New +$121K
MDGL icon
19
CALL
Madrigal Pharmaceuticals
MDGL
$12.8B
$116K 0.12%
+1,486
New +$125K
BGX
20
Blackstone Long-Short Credit Income Fund
BGX
$136M
-13,909
Closed -$224K
ESPR
21
DELISTED
Esperion Therapeutics
ESPR
-3,671
Closed -$340K
PSEC icon
22
Prospect Capital
PSEC
$1.13B
-36,527
Closed -$309K
TLPH icon
23
Talphera
TLPH
$68.5M
-1,094
Closed -$84K
XBI icon
24
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.4B
-7,596
Closed -$571K
TBRA
25
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
-1,259
Closed -$14K

Similar funds

Caxton Corporation's Q2 2015 Portfolio in Review

As of Q2 2015, Caxton Corporation held 26 positions worth $94.5M, up 13% from $83.8M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Caxton Corporation's Q2 2015 filing shows 6 new, 10 increased, 2 reduced and 7 closed positions. Its largest new stake was VanEck Gold Miners ETF: 73,274 shares worth $1.3M. The largest sale was RELYPSA INC COM, an estimated $405K.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 86% a quarter earlier, followed by Technology and Financials.

  • Caxton Corporation's largest Q2 2015 buy was VanEck Gold Miners ETF: 73,274 shares worth $1.3M.
  • Caxton Corporation added most to American Capital Ltd in Q2 2015, an estimated $165K increase.
  • Caxton Corporation's biggest Q2 2015 reduction was Agile Therapeutics, cutting an estimated $85.4K.
  • Caxton Corporation fully exited RELYPSA INC COM in Q2 2015, selling an estimated $405K.
  • Caxton Corporation's ten largest holdings make up 98% of its $94.5M portfolio in Q2 2015.
  • Caxton Corporation opened 6 new positions and closed 7 in Q2 2015.
  • Caxton Corporation's portfolio value rose 13% quarter-over-quarter to $94.5M.

Based on Caxton Corporation's 13F filing for Q2 2015, filed 14 Aug 2015.